Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02425943 · ClinicalTrials.gov registry record · Phase 4
Sculptra Aesthetic Post-Approval Study
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 867
- Enrollment target
NCT02425943 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 867 participants.
The verdict
NCT02425943, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 867 participants
- Enrollment target
Study Summary
Study is designed to assess the long-term safety of Sculptra Aesthetic in immune-competent subjects as a single regimen for correction of nasolabial fold (NLF) contour deficiencies and other facial wrinkles.
Interventions
- DEVICE injectable poly-L-lactic acid Sculptra Aesthetic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 867 participants |
| Start Date | 2015-05-21 |
| Est. Completion | 2021-05-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02425943
The ClinicalTrials.gov registry entry for NCT02425943 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 867 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which injectable poly-L-lactic acid Sculptra Aesthetic is the first listed.
NCT02425943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02425943 about?
NCT02425943 is a clinical study titled "Sculptra Aesthetic Post-Approval Study". Study is designed to assess the long-term safety of Sculptra Aesthetic in immune-competent subjects as a single regimen for correction of nasolabial fold (NLF) contour deficiencies and other facial wrinkles.
What is the current status of trial NCT02425943?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 867 participants. The study started on 2015-05-21. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT02425943?
The interventions under investigation include: injectable poly-L-lactic acid Sculptra Aesthetic (DEVICE).
Who is sponsoring clinical trial NCT02425943?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.